PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1880649
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1880649
The global multifilament/braided absorbable sutures market continues to grow steadily as demand for advanced wound-closure solutions rises across surgical disciplines. According to the latest report, the market was valued at USD 3.04 billion in 2024, driven by an increasing burden of chronic diseases and a higher volume of surgical procedures worldwide. The market is expected to expand to USD 3.20 billion in 2025 and further reach USD 5.51 billion by 2032, registering a strong CAGR of 8.0% during the forecast period.
Multifilament or braided absorbable sutures are made from twisted or braided strands designed to dissolve inside the body over time. Their superior tensile strength, flexibility, and secure knotting capacity make them ideal for internal surgical procedures, particularly where suture removal is not feasible. As global surgical volumes rise, demand for these sutures continues to accelerate.
Market Drivers
A significant rise in surgical procedures worldwide is driving market growth. Surgeries such as orthopedic, gynecological, cosmetic, and cardiovascular interventions rely heavily on absorbable sutures to promote rapid healing and reduce patient discomfort. For example, around 0.9 million rhinoplasty procedures were performed worldwide in 2022, increasing to 1.1 million in 2023, according to the International Society of Aesthetic Plastic Surgery. Similarly, caesarean deliveries in the U.K. increased from 34.7% in 2022 to 37.8% in 2023, contributing to rising demand for surgical sutures.
An expanding geriatric population, more prone to chronic illness and requiring frequent surgical care, further supports market growth. New product launches by leading players such as DemeTECH Corporation, Johnson & Johnson Services, Inc., Medtronic, and B. Braun SE also strengthen product availability across global markets.
Market Restraints
Despite growing demand, the market faces challenges due to rising adoption of alternative wound-closure methods. Surgical staplers, tissue adhesives, hemostats, and adhesive tapes are increasingly preferred in certain procedures due to benefits such as faster closure, reduced scarring, and minimized tissue trauma. For instance, according to Suture Planet's 2025 report, surgical staplers enable quicker and more secure closure compared to sutures, particularly in orthopedic and laparotomy surgeries.
This shift toward alternatives limits the adoption of multifilament/braided sutures, especially in regions with advanced healthcare systems. Additionally, postoperative complications such as suture infections, knot failures, scarring, and tissue reactions remain significant concerns among surgeons.
Market Opportunities
Expanding healthcare infrastructure in developing countries offers significant market opportunities. As new hospitals and surgical centers open across Asia Pacific, Latin America, and Africa, the overall number of surgical procedures continues to rise. For instance, Griffith Base Hospital opened in New South Wales in June 2025, illustrating the expanding infrastructure supporting surgical care.
Technological advancements-such as antimicrobial-coated sutures, synthetic bioengineered materials, and knotless absorbable sutures-are also creating new growth avenues. These innovations improve tissue healing, reduce infection risk, and simplify surgical workflows.
Market Challenges
Regulatory complexities remain a major challenge for manufacturers. Approval processes enforced by the U.S. FDA, EMA, and other regulatory bodies require extensive clinical data, increasing development costs and delaying market entry-particularly for small and mid-sized companies. Differences in regulatory requirements across regions further complicate global market expansion.
North America dominated the global market in 2024 with a market size of USD 1.30 billion, accounting for 42.76% of global share. Strong healthcare infrastructure, high surgical volumes, and extensive product availability fuel regional dominance.
Europe holds a moderate share, supported by rising surgical procedures such as the 100,606 cardiac surgeries performed in Germany in 2023.
Asia Pacific is expected to grow at the fastest CAGR due to expanding healthcare facilities, new product launches, and increasing medical tourism. Healthium Medtech's launch of TRUMAS sutures in 2023 highlights the region's growing innovation landscape.
Latin America and the Middle East & Africa will experience steady growth, supported by rising surgical volumes in general, orthopedic, ophthalmic, and cardiac care.
Conclusion
Projected to grow from USD 3.04 billion in 2024 to USD 5.51 billion by 2032, the multifilament/braided absorbable sutures market is set for robust expansion. Increasing surgical procedures, technological innovation, and expanding healthcare infrastructure will remain key drivers, despite challenges from alternative wound-closure methods and regulatory complexities.
Segmentation By Type, Application, End-user, and Region
By Type * Natural
By Application * Gynecology
By End-user * Hospitals & ASCs
By Region * North America (By Type, by Application, by End-user, and by Country)
U.S.
Canada
Germany
U.K.
France
Italy
Spain
Scandinavia
Rest of Europe
China
Japan
India
Australia
Southeast Asia
Rest of Asia Pacific
Brazil
Mexico
Rest of Latin America
GCC
South Africa
Rest of the Middle East & Africa